3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
21
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma, Non-Hodgkin
13
Lymphoma, Mantle-Cell
12
Lymphoma
12
Lymphoma, Follicular
10
Burkitt Lymphoma
7
Lymphoma, B-Cell, Marginal Zone
6
Lymphoma, B-Cell
6
Leukemia, Hairy Cell
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Leukemia
3
Waldenstrom Macroglobulinemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoproliferative Disorders
2
Leukemia, B-Cell
2
Infections
2
Epstein-Barr Virus Infections
2
beta-Thalassemia
1
Thalassemia
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphatic Diseases
1
Lymphadenopathy
1
Interventions
AZD 6244
6
trametinib
2
talimogene laherparepvec
1
omipalisib
1
lorlatinib
1
encorafenib
1
dabrafenib
1
binimetinib
1
abemaciclib
1
Specimen Handling
1
Sirolimus
1
N-monoacetylcystine
1
Lasers, Solid-State
1
Lasers
1
Inhalation
1
Curcumin
1
Cetuximab
1
Biopsy
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibromatosis 1
×
Rituximab
×
30 days
×
Clear all
No trials found.